In response to a university-based serogroup B meningococcal disease outbreak, the serogroup B meningococcal vaccine Trumenba was recommended for students, a rare instance in which a specific vaccine brand was recommended. This outbreak highlights the challenges of using molecular and immunologic data to inform real-time response.
Keywords: New Jersey; United States; bacteria; bacterial infection; infectious disease; meningitis/encephalitis; meningococcal meningitis; meningococcal vaccines; molecular diagnostic techniques; serogroup B; universities; vaccination recommendations.